Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ABT
Abbott Laboratories
stock NYSE

Market Open
May 9, 2025 1:16:30 PM EDT
134.25USD+0.187%(+0.25)1,483,183
134.21Bid   137.79Ask   3.58Spread
Pre-market
May 9, 2025 9:19:30 AM EDT
133.20USD-0.597%(-0.80)1,646
After-hours
May 8, 2025 4:42:30 PM EDT
134.13USD+0.067%(+0.09)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
12:02PM EST  What 5 Analyst Ratings Have To Say About Abbott Laboratories   Benzinga
07:35AM EST  Morgan Stanley Maintains Overweight on Abbott Laboratories, Lowers Price Target to $151   Benzinga
06:51AM EST  Raymond James Maintains Outperform on Abbott Laboratories, Lowers Price Target to $143   Benzinga
Jan 26, 2022
03:34PM EST  Abbott Laboratories Whale Trades For January 26   Benzinga
08:39AM EST  Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook   Benzinga
08:29AM EST  The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data   Benzinga
07:52AM EST  Abbott (ABT) reported fourth quarter earnings per share from continuing operations, excluding items, of $1.32 compared to $1.45, prior year. On average, 18 analysts polled by Thomson Reuters expected the company to report profit per share of $1.21, for the quarter. Analysts' estimates typically exclude special items.   RTTNews
07:42AM EST  Recap: Abbott Laboratories Q4 Earnings   Benzinga
07:35AM EST  Abbott Sees FY22 Adj. EPS $4.70+ vs $4.78 Est   Benzinga
07:35AM EST  Abbott Laboratories Q4 EPS $1.32 Beats $1.21 Estimate, Sales $11.50B Beat $10.71B Estimate   Benzinga
07:33AM EST  Abbott Q4 GAAP EPS $1.11 And Adj EPS $1.32   RTTNews
07:31AM EST  Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast   PR Newswire
05:16AM EST  A Peek Into The Markets: US Stock Futures Gain; Fed Policy Decision In Focus   Benzinga
03:59AM EST  Earnings Scheduled For January 26, 2022   Benzinga
Jan 25, 2022
10:06AM EST  A Preview Of Abbott Laboratories's Earnings   Benzinga
Jan 23, 2022
11:03AM EST  The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More   Benzinga
Jan 21, 2022
01:21PM EST  White House COVID Coordinator Zients Says COVID Tests Began Shipping Via USPS On Thursday   Benzinga
09:58AM EST  Price Over Earnings Overview: Abbott Laboratories   Benzinga
Jan 14, 2022
03:54PM EST  Abbott Spokesperson On The U.S. COVID-19 Testing Effort Tells Benzinga 'our operations, producing 70 million tests this month and further scaling toward 100 million a month to support federal, state and local governments, as well as employers, schools'   Benzinga
02:32PM EST  White House Official Says May Purchase More Than 1B At-Home Tests; Says 'We're Not Stopping There;' Orders Will Be Limited To 4 Tests Per Residential Address; Tests Will Ship Within 7-12 Days Of Ordering   Benzinga
Jan 12, 2022
11:56AM EST  FDA Clears Abbott's Latest EnSite Heart Mapping Platform   Benzinga
09:31AM EST  Abbott (ABT) said that it has received clearance from the U.S. Food and Drug Administration for the EnSite X EP System with EnSite Omnipolar Technology, a new cardiac mapping platform available in the U.S. and across Europe that is designed to help physicians better treat abnormal heart rhythms, also known as cardiac arrhythmias.   RTTNews
09:05AM EST  Abbott Receives FDA Clearance For New Cardiac Mapping System   Benzinga
09:03AM EST  Abbott : FDA Clears New Cardiac Mapping System To Improve How Doctors Treat Abnormal Heart Rhythms   RTTNews
09:01AM EST  Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve   PR Newswire
Jan 11, 2022
10:44AM EST  'FDA Acting Commissioner Woodcock on rapid tests. There are now total of 15 authorized by FDA. New program in place to accelerate review of these tests.' -News Nation Reporter   Benzinga
09:54AM EST  Price Over Earnings Overview: Abbott Laboratories   Benzinga
09:10AM EST  Abbott Laboratories Says Saw Surge In US And Internationally In COVID-19 Test Demand Around Thanksgiving And Christmas; Says COVID-19 Testing Will Eventually Be Ramped Down But There Will Be A Portion That Will Be Sustained   Benzinga
08:59AM EST  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jan. 11, 2022: PLUG, ABT, SBEV, WOOF, EAR   Benzinga
07:47AM EST  ACELYRIN Appoints Melanie Gloria As COO   RTTNews
07:45AM EST  ACELYRIN Appoints Melanie Gloria as Chief Operating Officer   PR Newswire
Jan 10, 2022
03:44PM EST  US Health & Human Services Says, Starting Jan. 15, 2022, Individuals With Private Health Insurance/Group Health Plan Who Buy Over-The-Counter COVID Tests Will Have Costs Covered By Plan/Insurance   Benzinga
02:28PM EST  White House Says Expects To Have All Contracts For New Rapid Test Awarded Over Next 2 Weeks   Benzinga
09:47AM EST  Wednesday Is Your Last Chance To Buy Abbott Laboratories Before The Dividend Payout   Benzinga
Jan 7, 2022
01:07PM EST  Abbott Laboratories CEO To Appear On CNBC Tech Check Today   Benzinga
01:04PM EST  Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $157   Benzinga
Jan 6, 2022
02:57PM EST  Abbot Pushing To Ramp Up Production Of At-Home Test Kits   Benzinga
01:16PM EST  Abbott Announces Future of Biowearables at Consumer Electronics Show   PR Newswire
Jan 5, 2022
10:48AM EST  Walmart And Kroger Jack Up Prices On COVID At-Home Tests After White House Agreement Not Extended   Benzinga
Jan 4, 2022
05:00PM EST  Abbott Hosts Conference Call for Fourth-Quarter Earnings   PR Newswire
09:14AM EST  Abbott Reports FDA Approval Of Its Expanded Proclaim XR Spinal Cord Stimulation System   Benzinga
09:04AM EST  Abbott's Proclaim XR Spinal Cord Stimulation System Offers Expanded MRI Compatibility In U.S.   RTTNews
09:00AM EST  Abbott's Proclaim(tm) XR Spinal Cord Stimulation System Now Offers Expanded MRI   PR Newswire
Dec 29, 2021
09:47AM EST  Price Over Earnings Overview: Abbott Laboratories   Benzinga
Dec 28, 2021
10:27AM EST  New York City To Double In-School PCR COVID Testing When Students Return   Benzinga
Dec 23, 2021
12:19PM EST  White House Still Working To Finalize Contracts For US Orders Of COVID Tests; COVID Testing Stocks Quiet   Benzinga
Dec 22, 2021
02:35PM EST  FDA Website Shows Dec. 22-Dated update On Antigen Tests For Omicron: 'The FDA continues to monitor and evaluate the impact of genetic variants on antigen tests...'   Benzinga
02:04PM EST  California Governor Newsom Says State Will Require Healthcare Workers To Get Covid-19 Vaccine Booster; Says California To Give Rapid Covid-19 Tests To All Public School Students After Winter Break   Benzinga
06:45AM EST  Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $150   Benzinga
Dec 21, 2021
04:56PM EST  EXCLUSIVE: Abbott Laboratories Spokesperson On Biden Admin. Efforts To Increase COVID Testing, Tells Benzinga: In January, we'll be making 70 million BinaxNOW rapid tests and can scale significantly further in the months ahead'   Benzinga
04:39PM EST  President Biden Tweets 'Starting this week, the federal government will set up emergency testing sites in areas that need additional testing capacity. Before Christmas, the first several of these federal testing sites will be up and running in New York..'   Benzinga
02:26PM EST  'Web site will be set up next month for any US household wanting to get free #coronavirus tests delivered, says @PressSec.' -Tweet   Benzinga
12:18PM EST  Fauci Says President Biden To Leverage Defense Production Act To Spur 200M To 500M COVID Tests To Market   Benzinga
12:17PM EST  New York Attorney General Issues Post 'Attorney General James Issues Warning to LabQ Diagnostics to Stop Misrepresenting Turnaround Times for COVID-19 Test Results'   Benzinga
09:02AM EST  Abbott to Present at J.P. Morgan Healthcare Conference   PR Newswire
07:58AM EST  Abbott Laboratories: Debt Overview   Benzinga
06:49AM EST  U.S, Equity Futures, European Markets Higher; Moderna on Monday Said Booster Dose Appears Effective vs Omicron; President Biden Promising 500M Free At-Home Covid Tests   Benzinga
05:42AM EST  President Biden to Announce Tuesday a Purchase of 500M At-home rapid Covid-19 Tests; Plan to Distribute them Free to Americans via Website   Benzinga
Dec 17, 2021
11:17AM EST  COVID Testing Plays Quiet Following Headline Biden Admin. Will Push For 'Test-To-Stay' Policy To Keep Kids In School   Benzinga
Dec 16, 2021
03:40PM EST  $1000 Invested In This Stock Over The Last 5 Years, Would Be Worth This Much   Benzinga
Dec 10, 2021
02:39PM EST  Abbott Names Robert Ford As Chairman Of Board   RTTNews
02:01PM EST  Abbott Names Robert For Chairman Of Board; Miles White To Retire As Executive Chairman   Benzinga
02:00PM EST  Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as   PR Newswire
01:51PM EST  Abbott Increases Quarterly Dividend To $0.47/share, Payable Feb. 15/ Record Jan. 14   RTTNews
01:29PM EST  Abbott Laboratories (ABT) Announces $5 Bln Stock Buyback   RTTNews
01:27PM EST  Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.47, Record Date 1/14/2022   RTTNews
01:01PM EST  Expert Ratings For Abbott Laboratories   Benzinga
01:00PM EST  Abbott Increases Quarterly Dividend for 50th Consecutive Year   PR Newswire
12:41PM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021   Benzinga
04:59AM EST  RBC Capital Initiates Coverage On Abbott Laboratories with Outperform Rating, Announces Price Target of $146   Benzinga
Dec 9, 2021
09:54PM EST  Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today   Benzinga
09:42PM EST  'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report   Benzinga
Dec 3, 2021
08:55AM EST  Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests   Benzinga
Dec 2, 2021
09:29AM EST  White House Chief Of Staff Ronald Klain Says President Biden Will Announce Today 'FREE and RELIABLE' COVID At Home Tests   Benzinga
Nov 30, 2021
04:48PM EST  Abbott Laboratories Says Already Conducted Assessment Of Omicron Variant And Confident Its Rapid And PCR Tests Can Detect The Virus   Benzinga
04:11PM EST  Fauci Says Already Have In Place Travel Testing Requirements   Benzinga
Nov 23, 2021
01:43PM EST  Abbott Laboratories Says Co's RealTime SARS-CoV-2 Assay Receives Authorization   Benzinga
Nov 16, 2021
01:03PM EST  Abbott Highlights Launch Of Similac 360 Total Care With Exclusive Blend Of 5 Human Milk Oligosaccharides Prebiotics   Benzinga
01:00PM EST  Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development   PR Newswire
08:31AM EST  The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment   Benzinga
Nov 15, 2021
10:49AM EST  Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on   PR Newswire
Nov 12, 2021
09:23AM EST  Abbott Laboratories (ABT) said that its new leadless pacemaker system met primary endpoints in pivotal trial.   RTTNews
09:03AM EST  Abbott Says New Leadless Pacemaker System Meets Primary Endpoints In Pivotal Trial   RTTNews
09:01AM EST  Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial   PR Newswire
Nov 9, 2021
09:03AM EST  Abbott , American Diabetes Association Launch Community Initiative In Columbus, Ohio, To Advance Access To Diabetes Care   RTTNews
09:02AM EST  Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology   PR Newswire
Nov 3, 2021
09:02AM EDT  Abbott Launches New Initiative to Drive Diversity in Medical Research and   PR Newswire
Oct 29, 2021
12:14PM EDT  UPDATE: SVB Leerink On DexCom Price Target Raise: Firm Highlights 'Still-Strong & Maybe Even Improving Fundamentals' Given Global Sales Growth Over Abbott Despite Continued Channel Mix Headwinds; Positive On Another Quarter Of 40%+ Volume Growth   Benzinga
Oct 27, 2021
12:23PM EDT  Where Abbott Laboratories Stands With Analysts   Benzinga
10:08AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021   Benzinga
06:16AM EDT  Atlantic Equities Upgrades Abbott Laboratories to Overweight, Announces $144 Price Target   Benzinga
Oct 25, 2021
11:07AM EDT  Kimberly-Clark's Earnings Remind Investors that Inflation and Supply Chain Issues are Still a Major Theme   Benzinga
Oct 22, 2021
04:26PM EDT  A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO   Benzinga
Oct 21, 2021
12:58PM EDT  Where Abbott Laboratories Stands With Analysts   Benzinga
12:12PM EDT  Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $146   Benzinga
12:11PM EDT  10 Biggest Price Target Changes For Thursday   Benzinga
12:11PM EDT  Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $134   Benzinga
12:11PM EDT  SVB Leerink Maintains Market Perform on Abbott Laboratories, Raises Price Target to $140   Benzinga
12:10PM EDT  A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings, Fed's Beige Book Report   Benzinga
Oct 20, 2021
10:34AM EDT  Abbot Labs and Biogen Outshine Novavax in the Health Care Sector   Benzinga
10:29AM EDT  A Crowded Earnings Calendar Ahead   Benzinga
10:01AM EDT  Why Abbott Shares Are Rising Today   Benzinga
08:16AM EDT  The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review   Benzinga
07:41AM EDT  While reporting financial results for the third quarter on Wednesday, Abbott Laboratories (ABT) raised its earnings and adjusted earnings guidance for the full-year 2021.   RTTNews
07:35AM EDT  Abbott Laboratories Raises FY21 EPS Guidance From $4.30-$4.50 To $5.00-$5.10 Vs. $4.45 Est.   Benzinga
07:34AM EDT  Abbott Laboratories (ABT) released earnings for its third quarter that advanced from last year.   RTTNews
07:33AM EDT  Abbott Laboratories Q3 EPS $1.40 Beats $0.94 Estimate, Sales $10.90B Beat $9.54B Estimate   Benzinga
07:32AM EDT  Abbott Reports Q3 Sales Growth Of 23.4%; Organic Sales Growth Of 22.4%   RTTNews
07:31AM EDT  Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit   PR Newswire
05:59AM EDT  A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings, Fed Minutes   Benzinga
03:44AM EDT  Earnings Scheduled For October 20, 2021   Benzinga
Oct 19, 2021
10:15AM EDT  Abbott Laboratories's Earnings Outlook   Benzinga
Oct 18, 2021
09:23AM EDT  Jason Sudeikis Joins Abbott, Real Madrid at New York Stock Exchange to Support   PR Newswire
07:34AM EDT  The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs   Benzinga
07:02AM EDT  Abbott, Real Madrid Partner To Support Health And Nutrition Of Children Globally   RTTNews
07:01AM EDT  Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children   PR Newswire
Oct 14, 2021
04:01PM EDT  FDA Issues Press Release :Abbott Molecular, Inc. Recalls Alinity m SARS-CoV-2 AMP Kit and Alinity m Resp-4-Plex AMP Kit for Potential False Positive SARS-CoV-2 Test Results   Benzinga
02:29PM EDT  UPDATE: Abbott Molecular Recalls Alinity M SARS-CoV-2 AMP Kit And Alinity M Resp-4-Plex AMP Kit For Potential False Positive Test Results   Benzinga
02:22PM EDT  Abbott Shares Tick Slightly Lower As Hearing FDA Says Co.'s COVID Kits Have Been Recalled Amid False-Positive Risk   Benzinga
12:41PM EDT  Expert Ratings For Abbott Laboratories   Benzinga
11:18AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021   Benzinga
09:04AM EDT  Quipt Reaches Significant Milestone with Fresh Acquisition and Announces new EVP of Operations   Benzinga
07:08AM EDT  Redburn Partners Initiates Coverage On Abbott Laboratories with Neutral Rating   Benzinga
Oct 13, 2021
01:38PM EDT  Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock   Benzinga
Oct 6, 2021
07:26AM EDT  Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters   Benzinga
Sep 30, 2021
09:56AM EDT  Abbott Invests $45 Mln Annually To Help Identify, Treat And Prevent Malnutrition   RTTNews
09:49AM EDT  Abbott Commits to Reducing Malnutrition Globally with Launch of Abbott Center   PR Newswire
Sep 29, 2021
05:01PM EDT  FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants   Benzinga
Sep 24, 2021
01:25PM EDT  Semiconductor Shortage Hits Supply Chain For MedTech Industry   Benzinga
01:21PM EDT  FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations   Benzinga
Sep 23, 2021
02:12PM EDT  Abbott Labs Wins $2.1M Navy Contract For 'Chemistry Analyzer-Bremerton'   Benzinga
09:01AM EDT  Abbott Hosts Conference Call for Third-Quarter Earnings   PR Newswire
Sep 20, 2021
09:13AM EDT  Abbott Reports FDA Approval For Portico With FlexNav TAVR   RTTNews
09:02AM EDT  Abbott : FDA Approves Minimally Invasive Portico With FlexNav TAVR System To Treat Patients With Aortic Valve Disease   RTTNews
09:01AM EDT  Abbott Receives FDA Approval For Minimally Invasive Portico With FlexNav TAVR System To Treat Patients With Aortic Valve Disease   Benzinga
09:01AM EDT  Abbott Receives FDA Approval for Minimally Invasive Portico(tm) with   PR Newswire
06:35AM EDT  FDA Warns On Potential False Positive Results With Abbott's COVID-19 Lab Tests   Benzinga
Sep 17, 2021
11:24AM EDT  FDA Alerting Health Care Providers Of Potential For False Positive Results With Alinity M Sars-CoV-2 AMP Kit, Alinity M Resp-4-Plex AMP Kit   Benzinga
Sep 15, 2021
02:38PM EDT  Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.45, Record Date 10/15/2021   RTTNews
02:09PM EDT  Abbott Declares Quarterly Dividend Of $0.45/share, Payable Nov. 15/ Record Oct. 15   RTTNews
12:47PM EDT  Abbott Declares 391st Consecutive Quarterly Dividend   PR Newswire
Sep 14, 2021
07:50AM EDT  The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout   Benzinga
Sep 10, 2021
07:36PM EDT  Abbott Laboratories Says Quickly Working To Scale Back Up Our Manufacturing Of BinaxNOW, ID Test Kits, Including Hiring Additional Employees   Benzinga
Sep 9, 2021
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
Sep 7, 2021
11:01AM EDT  Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High   Benzinga
Sep 3, 2021
07:31AM EDT  The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself   Benzinga
Sep 2, 2021
09:58AM EDT  Abbott (ABT) has acquired Walk Vascular, a commercial-stage medical device company. Walk Vascular's peripheral thrombectomy systems will be incorporated into the company's endovascular product portfolio. Financial terms of the deal were not disclosed.   RTTNews
09:32AM EDT  Abbott Acquires Walk Vascular; Financial Terms Not Disclosed   RTTNews
09:31AM EDT  Abbott Acquires Walk Vascular; Terms Not Disclosed   Benzinga
09:30AM EDT  Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular,   PR Newswire
Aug 31, 2021
08:24AM EDT  BTIG Maintains Buy on Abbott Laboratories, Raises Price Target to $136   Benzinga
Aug 30, 2021
03:47PM EDT  Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study   Benzinga
11:56AM EDT  Abbott Laboratories Says Late-Breaking Data Shows Co's Amplatzer Amulet Occluder Offers 'Superior Left Atrial Appendage Closure' Compared To Watchman Device For People With Atrial Fibrillation At Risk Of Stroke   Benzinga
11:55AM EDT  Superior Left Atrial Appendage Closure Compared to Watchman? Device for People With Atrial Fibrillation at Risk of Stroke   PR Newswire
Aug 27, 2021
09:08AM EDT  Abbott: CardioMEMS Device Shows Potential Benefits In New   RTTNews
08:50AM EDT  Abbott : GUIDE-HF Study Data Show CardioMEMS Device Can Improve Care For More Patients With Heart Failure   RTTNews
08:49AM EDT  Abbott Highlights Results Of GUIDE-HF Trial Assessing CardioMEMS Device   Benzinga
08:47AM EDT  GUIDE-HF Study Data Show Abbott's CardioMEMS(tm) Device Can Improve Care for   PR Newswire
06:23AM EDT  See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests   Benzinga
Aug 23, 2021
05:36PM EDT  Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT   Benzinga
Aug 21, 2021
11:22AM EDT  Where Abbott Laboratories Stands With Analysts   Benzinga
Aug 20, 2021
03:25PM EDT  'Maker of Popular Covid Test Told Factory to Destroy Inventory' -New York Times Report   Benzinga
Aug 16, 2021
03:09PM EDT  FDA Approves Abbott's Atrial Fibrillation Device For LAA Occlusion   Benzinga
08:27AM EDT  Abbott Laboratories (ABT) announced Monday that the U.S. Food and Drug Administration (FDA) approved the company's Amplatzer Amulet Left Atrial Appendage Occluder to treat people with atrial fibrillation (AFib) who are at risk of ischemic stroke.   RTTNews
08:02AM EDT  FDA Approves Abbott's Amplatzer Amulet Device To Treat People With Atrial Fibrillation At Risk Of Stroke   RTTNews
08:02AM EDT  Abbott's Amplatzer Amulet Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke   Benzinga
08:00AM EDT  Abbott's Amplatzer(tm) Amulet(tm) Device Approved by FDA to Treat People With   PR Newswire
Aug 11, 2021
11:32AM EDT  Abbott Laboratories, Cereno Scientific Enter Collaboration For Use Of Cutting-Edge Monitor Device In Upcoming Phase 2 Study With CS1   Benzinga
Aug 3, 2021
09:47AM EDT  Abbott Laboratories (ABT) announced Tuesday that it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software.   RTTNews
09:04AM EDT  Abbott Receives FDA Clearance For Imaging Technology Using Artificial Intelligence For Vessels In The Heart   Benzinga
09:03AM EDT  Abbott Receives FDA Clearance for its Imaging Technology Using Artificial   PR Newswire
09:02AM EDT  Abbott Receives FDA Clearance For Imaging Technology Using Artificial Intelligence For Vessels In The Heart   RTTNews
Aug 2, 2021
10:48AM EDT  U.S. Says Arriva Medical, Parent Alere To Pay $160M To Resolve Alleged False Claims To Medicare   Benzinga
09:22AM EDT  Abbott said that the U.S. Food and Drug Administration has cleared the FreeStyle Libre 2 iOS application for use with compatible iPhones, providing a comprehensive digital offering for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system.   RTTNews
09:04AM EDT  Abbott's FreeStyle Libre 2 IOS App Approved In U.S., Provides Simplify Diabetes Management   RTTNews
09:03AM EDT  Abbott Reports Its FreeStyle Libre 2 iOS App Cleared In US   Benzinga
09:00AM EDT  Abbott's FreeStyle(r) Libre 2 iOS App Cleared in U.S., Providing a Seamless   PR Newswire
Jul 30, 2021
01:10PM EDT  Abbott Launches Latest Insertable Cardiac Monitor For Irregular Heart Rhythms   Benzinga
Jul 29, 2021
09:02AM EDT  Abbott New Study: Half Of Americans Living With Diabetes May Be Consuming Less Than Recommended Amount Of Protein   RTTNews
09:00AM EDT  the Recommended Amount of Protein, which is Associated with Greater Physical Limitations   PR Newswire
Jul 23, 2021
02:58PM EDT  Where Abbott Laboratories Stands With Analysts   Benzinga
09:23AM EDT  Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $136   Benzinga
08:56AM EDT  Credit Suisse Maintains Outperform on Abbott Laboratories, Raises Price Target to $130   Benzinga
08:33AM EDT  Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $128   Benzinga
Jul 22, 2021
11:34AM EDT  The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO   Benzinga
09:21AM EDT  Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance   Benzinga
08:18AM EDT  The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO   Benzinga
08:14AM EDT  Abbott Q2 Profit More Than Doubles As Medical Device Sales Rebound   Benzinga
07:44AM EDT  Abbott Laboratories Maintains FY21 Outlook - Quick Facts   RTTNews
07:35AM EDT  Abbott Laboratories (ABT) released a profit for its second quarter that increased from the same period last year.   RTTNews
07:35AM EDT  Abbott Laboratories: Q2 Earnings Insights   Benzinga
07:23AM EDT  Abbott Q2 Sales Growth Of 39.5%; Organic Sales Growth Of 35.0%   RTTNews
07:20AM EDT  Abbott Says Continues To Project FY21 Adj. EPS $4.30-$4.50 vs $4.36 Est.   Benzinga
07:18AM EDT  Abbott Laboratories Q2 Adj. EPS $1.17 Beats $1.02 Estimate, Sales $10.20B Beat $9.69B Estimate   Benzinga
07:15AM EDT  Abbott Reports Second-Quarter 2021 Results   PR Newswire
06:01AM EDT  A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings, Economic Data   Benzinga
04:02AM EDT  Earnings Scheduled For July 22, 2021   Benzinga
Jul 21, 2021
10:37AM EDT  Earnings Preview: Abbott Laboratories   Benzinga
Jul 20, 2021
12:10PM EDT  SVB Leerink Maintains Market Perform on Abbott Laboratories, Raises Price Target to $128   Benzinga
10:33AM EDT  A Look Into Abbott Laboratories Price Over Earnings   Benzinga
Jul 12, 2021
07:50AM EDT  Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $135   Benzinga
Jul 9, 2021
02:21PM EDT  Abbott Lays Off Around 400 Employees As COVID-19 Test Demand Evaporates   Benzinga
Jul 8, 2021
11:25PM EDT  St. Jude Medical Inc. agreed to pay $27 million to settle allegations that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal health care programs, the U.S. Department of Justice said in a statement.   RTTNews
Jul 7, 2021
10:32AM EDT  Abbott Laboratories Sells STARLIMS Informatics Product Suite And Related Business Assets To Francisco Partners; Terms Not Disclosed   Benzinga
Jun 30, 2021
09:22AM EDT  Abbott (ABT) said that its XIENCE family of stents has received U.S. Food and Drug Administration approval for one-month (as short as 28 days) DAPT labeling for high bleeding risk (HBR) patients in the U.S.   RTTNews
09:03AM EDT  Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course   PR Newswire
09:03AM EDT  Abbott's XIENCE Stent Gets FDA Approval For Shortest Blood Thinner Course For High Bleeding Risk Patients   RTTNews
09:01AM EDT  Abbott Reports Its XIENCE Stent Received FDA Approval For Shortest Blood Thinner Course For High Bleeding Risk Patients   Benzinga
Jun 25, 2021
11:31AM EDT  Late-Breaking Data Demonstrate Abbott's FreeStyle Libre System Supports Health Equity for Millions of Americans Living with Diabetes   Benzinga
11:30AM EDT  Late-Breaking Data Demonstrate Abbott's FreeStyle(r) Libre System Supports   PR Newswire
09:00AM EDT  Abbott Hosts Conference Call for Second-Quarter Earnings   PR Newswire
Jun 24, 2021
09:00AM EDT  People Who Exercise Intensely Could Improve Recovery by Adjusting Their   PR Newswire
Jun 23, 2021
11:46AM EDT  Where Abbott Laboratories Stands With Analysts   Benzinga
09:25AM EDT  Citius Shows a Promising Future as Share Prices Keep Going up   Benzinga
Jun 22, 2021
07:00AM EDT  Abbott Earns First-of-its-Kind Recommendation for High School STEM Interns to   PR Newswire
Jun 18, 2021
10:21AM EDT  Return On Capital Employed Overview: Abbott Laboratories   Benzinga
07:46AM EDT  Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic   Benzinga
Jun 11, 2021
11:48AM EDT  Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.45, Record Date 7/15/2021   RTTNews
11:29AM EDT  Abbott Declares Quarterly Dividend Of $0.45/share, Payable Aug. 16/ Record July 15   RTTNews
11:20AM EDT  Abbott Declares 390th Consecutive Quarterly Dividend   PR Newswire
Jun 3, 2021
04:25PM EDT  Abbott Laboratories Approves Restructuring Plan, Sees Pre-Tax Costs To Be $550M-$700M; Costs Expected To Be Incurred During Remainder Of 2021 With Majority Of Costs Expected To Be Recorded In Q2 Of 2021   Benzinga
10:48AM EDT  Where Abbott Laboratories Stands With Analysts   Benzinga
07:09AM EDT  Abbott Says Has Capacity And Supply To Support Demand For MCS Devices   Benzinga
07:03AM EDT  Abbott Confirms Capacity To Support Expanded Use Of HeartMate 3 Heart Pump   RTTNews
07:01AM EDT  Abbott Confirms Capacity to Support Expanded Use of HeartMate 3(tm) Heart Pump   PR Newswire
Jun 2, 2021
08:43AM EDT  Morgan Stanley Maintains Overweight on Abbott Laboratories, Lowers Price Target to $126   Benzinga
08:39AM EDT  Credit Suisse Maintains Outperform on Abbott Laboratories, Lowers Price Target to $120   Benzinga
08:38AM EDT  BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $120   Benzinga
07:41AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
07:14AM EDT  Raymond James Maintains Outperform on Abbott Laboratories, Lowers Price Target to $116   Benzinga
07:04AM EDT  Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $125   Benzinga
06:47AM EDT  Wells Fargo Maintains Overweight on Abbott Laboratories, Lowers Price Target to $125   Benzinga
06:43AM EDT  Barclays Maintains Overweight on Abbott Laboratories, Lowers Price Target to $125   Benzinga
Jun 1, 2021
12:29PM EDT  American Airlines Says Self-Administered Abbott Binaxnow Home Text Through EMED Available For International Travel To U.S.   Benzinga
10:06AM EDT  What Does Abbott Laboratories Debt Look Like?   Benzinga
09:58AM EDT  Shares of Abbott Laboratories (ABT) are down more than 5% Tuesday morning after the company cut its full-year earnings outlook, citing lower Covid-19 testing demand.   RTTNews
08:21AM EDT  Providing an update to its financial outlook on Tuesday, Abbott Laboratories (ABT) lowered its earnings and adjusted earnings guidance for the full-year 2021, due to significantly lower recent and projected COVID-19 diagnostic testing demand. The company also issued outlook for the second quarter.   RTTNews
08:05AM EDT  Abbott Says Updated Outlook Reflects Lower Recent And Projected Demand For COVID-19 Tests   Benzinga
08:04AM EDT  Abbott Sees FY21 Adj. EPS $4.30-$4.50 vs $5.04 Est.   Benzinga
08:02AM EDT  Abbott Now Projects 2021 GAAP EPS From Cont Operations Of $2.75 To $2.95 And Adj EPS From Cont Opns Of $4.30 To $4.50   RTTNews
08:02AM EDT  Abbott Issues Updated 2021 Outlook   PR Newswire
May 26, 2021
09:52AM EDT  The Power and Precision of BioSig's PURE EP System in the Electrophysiology (EP) Market   Benzinga
May 25, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021   Benzinga
06:45AM EDT  Barclays Initiates Coverage On Abbott Laboratories with Overweight Rating, Announces Price Target of $150   Benzinga
May 24, 2021
09:44AM EDT  The Power and Precision of BioSig's PURE EP System in the Electrophysiology (EP) Market   Benzinga
May 17, 2021
04:59PM EDT  Abbott's Navitor Aortic Heart Valve Replacement Scores European Approval   Benzinga
09:06AM EDT  Abbott Receives CE Mark For Its Latest-generation Transcatheter Aortic Valve Implantation System, Navitor   RTTNews
09:02AM EDT  Abbott Receives CE Mark for Navitor(tm), the Latest-Generation Transcatheter   PR Newswire
May 13, 2021
01:34PM EDT  'Abbott (formally known as "St. Jude Medical") Recalls Assurity and Endurity Pacemakers for Potential Moisture Ingress Causing Electrical Short and Reduced Battery Life' -FDA Recall   Benzinga
May 12, 2021
01:01PM EDT  United Airlines, Abbott Partner To Make Return To U.S. 'Worry Free' For International Travelers With Home-Testing Kits   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC